For instance, mutations in FUS and other on low-sequence complexity domain proteins (and/or their increased concentration) have been proposed to accelerate their aggregation in neurodegenerative diseases, possibly by enhanced stress granule formation10 and through a liquid-to-solid phase transition7. This evidence concerns the gene FUS and neurodegenerative disease.